These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 17684460)
1. Albuminuria and chronic kidney disease in association with the metabolic syndrome. Ninomiya T; Kiyohara Y J Cardiometab Syndr; 2007; 2(2):104-7. PubMed ID: 17684460 [TBL] [Abstract][Full Text] [Related]
2. The metabolic syndrome and chronic kidney disease in U.S. adults. Chen J; Muntner P; Hamm LL; Jones DW; Batuman V; Fonseca V; Whelton PK; He J Ann Intern Med; 2004 Feb; 140(3):167-74. PubMed ID: 14757614 [TBL] [Abstract][Full Text] [Related]
4. Preventing cardiovascular and renal complications in the management of hypertension and metabolic syndrome. Chen J; Townsend RR Expert Opin Pharmacother; 2007 Sep; 8(13):2001-9. PubMed ID: 17714054 [TBL] [Abstract][Full Text] [Related]
5. Summaries for patients. Association of the metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med; 2004 Feb; 140(3):I39. PubMed ID: 14757631 [No Abstract] [Full Text] [Related]
6. [Impact of metabolic syndrome on chronic kidney disease]. Calò LA Minerva Med; 2006 Dec; 97(6):451-8. PubMed ID: 17213781 [TBL] [Abstract][Full Text] [Related]
7. Association of metabolic syndrome and chronic kidney disease. Scurt FG; Ganz MJ; Herzog C; Bose K; Mertens PR; Chatzikyrkou C Obes Rev; 2024 Jan; 25(1):e13649. PubMed ID: 37783465 [TBL] [Abstract][Full Text] [Related]
8. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria. Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229 [TBL] [Abstract][Full Text] [Related]
9. Renal manifestations in the metabolic syndrome. Locatelli F; Pozzoni P; Del Vecchio L J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S81-5. PubMed ID: 16565254 [TBL] [Abstract][Full Text] [Related]
10. The Effect of Lipotoxicity on Renal Dysfunction in a Nonobese Rat Model of Metabolic Syndrome: A Urinary Proteomic Approach. Markova I; Miklankova D; Hüttl M; Kacer P; Skibova J; Kucera J; Sedlacek R; Kacerova T; Kazdova L; Malinska H J Diabetes Res; 2019; 2019():8712979. PubMed ID: 31886287 [TBL] [Abstract][Full Text] [Related]
11. Association of albuminuria and the metabolic syndrome. Rowley K; O'Dea K; Best JD Curr Diab Rep; 2003 Feb; 3(1):80-6. PubMed ID: 12643150 [TBL] [Abstract][Full Text] [Related]
12. Time to abandon microalbuminuria? Ruggenenti P; Remuzzi G Kidney Int; 2006 Oct; 70(7):1214-22. PubMed ID: 16871239 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS). Jia W; Gao X; Pang C; Hou X; Bao Y; Liu W; Wang W; Zuo Y; Gu H; Xiang K Nephrol Dial Transplant; 2009 Dec; 24(12):3724-31. PubMed ID: 19617258 [TBL] [Abstract][Full Text] [Related]
15. Triad of metabolic syndrome, chronic kidney disease, and coronary heart disease with a focus on microalbuminuria death by overeating. Gobal F; Deshmukh A; Shah S; Mehta JL J Am Coll Cardiol; 2011 Jun; 57(23):2303-8. PubMed ID: 21636030 [TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome, insulin resistance, and chronic allograft dysfunction. Porrini E; Delgado P; Torres A Kidney Int Suppl; 2010 Dec; (119):S42-6. PubMed ID: 21116317 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular and renal effects of weight reduction in obesity and the metabolic syndrome. Cohen JB; Cohen DL Curr Hypertens Rep; 2015 May; 17(5):34. PubMed ID: 25833456 [TBL] [Abstract][Full Text] [Related]